These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9754593)

  • 1. Consecutive screening and enrollment in clinical trials: the way to representative patient samples?
    Bjørn M; Brendstrup C; Karlsen S; Carlsen JE
    J Card Fail; 1998 Sep; 4(3):225-30; discussion 231. PubMed ID: 9754593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consecutive screening and enrollment in clinical trials.
    Julian D
    J Card Fail; 1998 Sep; 4(3):233. PubMed ID: 9754594
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for patient recruitment into clinical trials.
    Yusuf S
    J Card Fail; 1998 Sep; 4(3):235-6. PubMed ID: 9754595
    [No Abstract]   [Full Text] [Related]  

  • 4. Validity versus generalizability in clinical trial design and conduct.
    Hennekens CH; Buring JE
    J Card Fail; 1998 Sep; 4(3):239-41. PubMed ID: 9754597
    [No Abstract]   [Full Text] [Related]  

  • 5. Consecutive screening and enrollment on clinical trials.
    Bjørn M; Brendstrup C; Karlsen S; Carlsen JE
    J Card Fail; 1999 Sep; 5(3):283-4. PubMed ID: 10496202
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
    Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
    Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
    Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
    BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To screen or not to screen: how to improve clinical trials.
    Held P; Swedberg K
    J Card Fail; 1998 Sep; 4(3):237-8. PubMed ID: 9754596
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials in heart failure: can we expect the results to be replicated in clinical practice?
    Massie BM
    J Card Fail; 1998 Sep; 4(3):243-7. PubMed ID: 9754598
    [No Abstract]   [Full Text] [Related]  

  • 10. Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.
    Cottin V; Arpin D; Lasset C; Cordier JF; Brune J; Chauvin F; Trillet-Lenoir V
    Ann Oncol; 1999 Jul; 10(7):809-15. PubMed ID: 10470428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement Initiative to Develop and Implement a Tool for Detecting Drug-Drug Interactions During Oncology Clinical Trial Enrollment Eligibility Screening.
    Marcath LA; Coe TD; Shakeel F; Reynolds E; Bayuk M; Haas S; Redman BG; Wong SF; Hertz DL
    J Patient Saf; 2021 Jan; 17(1):e28-e34. PubMed ID: 33003175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A guide to successfully recruiting patients for cardiovascular clinical trials.
    DeSantis P; Gross LS; DeLuca S
    Prog Cardiovasc Nurs; 1997; 12(3):24-31. PubMed ID: 9287364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.
    Beck JT; Rammage M; Jackson GP; Preininger AM; Dankwa-Mullan I; Roebuck MC; Torres A; Holtzen H; Coverdill SE; Williamson MP; Chau Q; Rhee K; Vinegra M
    JCO Clin Cancer Inform; 2020 Jan; 4():50-59. PubMed ID: 31977254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare premium buy-in programs: results of SSA demonstration projects.
    Nadel M; Alecxih L; Parent R; Sears J
    Soc Secur Bull; 2000; 63(3):26-33. PubMed ID: 11439703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effort required in eligibility screening for clinical trials.
    Penberthy LT; Dahman BA; Petkov VI; DeShazo JP
    J Oncol Pract; 2012 Nov; 8(6):365-70. PubMed ID: 23598846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
    Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
    J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Time-and-Motion Study of Clinical Trial Eligibility Screening in a Pediatric Emergency Department.
    Dexheimer JW; Tang H; Kachelmeyer A; Hounchell M; Kennebeck S; Solti I; Ni Y
    Pediatr Emerg Care; 2019 Dec; 35(12):868-873. PubMed ID: 30281551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of systematic screening for the detection of atrial fibrillation.
    Moran PS; Flattery MJ; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009586. PubMed ID: 23633374
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.